Table 3.
Name | Established Association with Proliferative Vitreoretinopathy |
Possible Mechanism | Possible Use in Clinical Practice | Reference |
---|---|---|---|---|
ephrinB2 and EphB4 | Expression in PVR membranes | Effect on migration and transdifferentiation of RPE cells | Potential therapeutic target | [63] |
EphB4 | Reduction of PDGF-induced migration and proliferation of RPE cells by the soluble form of EphB4 |
Reduction in FAK and p42/44 MAPK dependent phosphorylation | Potential therapeutic target | [69] |